We are live on ! Find out more
NFYS.WS

Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS

Delisted

NFYS.WS was delisted on the 24th of July, 2024.

31 hedge funds and large institutions have $15.5M invested in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

15% more funds holding

Funds holding: 2731 (+4)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

6% less capital invested

Capital invested by funds: $16.4M → $15.5M (-$944K)

Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
4
Closed
3
Calls
$7.81M
Puts
Net Calls
+$7.81M
Net Calls Change
-$81K
Name Holding Trade Value Shares
Change
Change in
Stake
MC
26
Meteora Capital
Florida
$2K +$3.2K +13,848 New
SIA
27
SkyView Investment Advisors
New Jersey
$1K +$936 +4,051 New
SCM
28
Segantii Capital Management
Hong Kong
$258
MF
29
Magnetar Financial
Illinois
$15 +$14.7K +63,500 New
Citadel Advisors
30
Citadel Advisors
Florida
-$82K -295,292 Closed
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
-$16K -58,376 Closed
FLC
32
Fifth Lane Capital
Texas
-$4K -12,500 Closed
CS
33
Clear Street
New York
+$577 +2,499 New

NFYS.WS Hedge Fund Activity: Q2 2022 in Review

31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) for Q2 2022, worth a combined $15.5M — down 5.8% from $16.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NFYS.WS positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was CAAS Capital Management, opening a new position worth an estimated $237K. The largest seller was Citadel Advisors, exiting entirely with an estimated $82K sold.

  • 31 institutional investors held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) as of Q2 2022, up from 27 in Q1 2022.
  • Funds reported $15.5M of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 stock for Q2 2022, down 5.8% quarter-over-quarter.
  • 7 funds opened new Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 positions in Q2 2022 and 3 closed out, a net change of +4 holders.
  • The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 buyer in Q2 2022 was CAAS Capital Management, an estimated $237K added.
  • The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 seller in Q2 2022 was Citadel Advisors, an estimated $82K sold.

Based on aggregated 13F filings for Q2 2022.